DPP4 and diabetes mellitus: The results of the present study correspond well with those of previous studies showing that the CVD (including HF) hospitalization rate did not increase with the use of incretin-based drugs or DPP-4 inhibitors compared with the use of oral antidiabetic drugs in patients with diabetes.[12,16,17,24]